RE-BCG-CoV-19: BCG revaccination for healthcare workers in SARS-CoV-2 pandemic
- Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
- Total publications:3 publications
Grant number: RIA2020EF-2968
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$545,000Funder
European & Developing Countries Clinical Trials Partnership (EDCTP)Principal Investigator
Dr. Andreas DiaconResearch Location
South AfricaLead Research Institution
Task Foundation NPCResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Health Personnel
Abstract
The RE-BCG-CoV-19 project (RIA2020EF-2968) aims to investigate whether and why BCG-revaccination can reduce infection rate and/or disease severity in healthcare workers during the SARS-CoV-2 virus disease outbreak in South Africa.
Publicationslinked via Europe PMC
Last Updated:5 days ago
View all publications at Europe PMC